Literature DB >> 26639989

Antiplatelet therapy: Net benefit of ticagrelor in patients with chronic kidney disease.

Noel C Chan1, Jacqueline Bosch2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26639989     DOI： 10.1038/nrneph.2015.196

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  9 in total

1.  Rivaroxaban in patients with a recent acute coronary syndrome.

Authors:  Jessica L Mega; Eugene Braunwald; Stephen D Wiviott; Jean-Pierre Bassand; Deepak L Bhatt; Christoph Bode; Paul Burton; Marc Cohen; Nancy Cook-Bruns; Keith A A Fox; Shinya Goto; Sabina A Murphy; Alexei N Plotnikov; David Schneider; Xiang Sun; Freek W A Verheugt; C Michael Gibson
Journal:  N Engl J Med       Date:  2011-11-13       Impact factor: 91.245

2.  Renal function, atherothrombosis extent, and outcomes in high-risk patients.

Authors:  Raphaelle L Dumaine; Gilles Montalescot; Ph Gabriel Steg; E Magnus Ohman; Kim Eagle; Deepak L Bhatt
Journal:  Am Heart J       Date:  2009-07       Impact factor: 4.749

3.  Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial.

Authors:  Stefan James; Andrzej Budaj; Philip Aylward; Kristen K Buck; Christopher P Cannon; Jan H Cornel; Robert A Harrington; Jay Horrow; Hugo Katus; Matyas Keltai; Basil S Lewis; Keyur Parikh; Robert F Storey; Karolina Szummer; Daniel Wojdyla; Lars Wallentin
Journal:  Circulation       Date:  2010-08-30       Impact factor: 29.690

4.  Long-term use of ticagrelor in patients with prior myocardial infarction.

Authors:  Marc P Bonaca; Deepak L Bhatt; Marc Cohen; Philippe Gabriel Steg; Robert F Storey; Eva C Jensen; Giulia Magnani; Sameer Bansilal; M Polly Fish; Kyungah Im; Olof Bengtsson; Ton Oude Ophuis; Andrzej Budaj; Pierre Theroux; Mikhail Ruda; Christian Hamm; Shinya Goto; Jindrich Spinar; José Carlos Nicolau; Robert G Kiss; Sabina A Murphy; Stephen D Wiviott; Peter Held; Eugene Braunwald; Marc S Sabatine
Journal:  N Engl J Med       Date:  2015-03-14       Impact factor: 91.245

5.  Prasugrel versus clopidogrel in patients with acute coronary syndromes.

Authors:  Stephen D Wiviott; Eugene Braunwald; Carolyn H McCabe; Gilles Montalescot; Witold Ruzyllo; Shmuel Gottlieb; Franz-Joseph Neumann; Diego Ardissino; Stefano De Servi; Sabina A Murphy; Jeffrey Riesmeyer; Govinda Weerakkody; C Michael Gibson; Elliott M Antman
Journal:  N Engl J Med       Date:  2007-11-04       Impact factor: 91.245

6.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

7.  Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry.

Authors:  Caroline S Fox; Paul Muntner; Anita Y Chen; Karen P Alexander; Matthew T Roe; Christopher P Cannon; Jorge F Saucedo; Michael C Kontos; Stephen D Wiviott
Journal:  Circulation       Date:  2010-01-11       Impact factor: 29.690

8.  Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in relation to renal function: insights from the PEGASUS-TIMI 54 trial.

Authors:  Giulia Magnani; Robert F Storey; Gabriel Steg; Deepak L Bhatt; Marc Cohen; Julia Kuder; Kyungah Im; Philip Aylward; Diego Ardissino; Daniel Isaza; Alexander Parkhomenko; Assen R Goudev; Mikael Dellborg; Frederic Kontny; Ramon Corbalan; Felix Medina; Eva C Jensen; Peter Held; Eugene Braunwald; Marc S Sabatine; Marc P Bonaca
Journal:  Eur Heart J       Date:  2015-10-05       Impact factor: 29.983

Review 9.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Authors:  Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson
Journal:  Circulation       Date:  2003-10-28       Impact factor: 29.690
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.